GT Biopharma, Inc. (GTBP)

0.8448 +0.04 (+4.94%) USD  |  NASDAQ  |  Dec 24, 12:59
0.8448 0.00 (0.00%) After-Hours: 13:59
More

GT Biopharma SG&A Expense (TTM): 6.564M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 2.717B
Plus Therapeutics, Inc. 11.09M
Geron Corp. 160.96M
SELLAS Life Sciences Group, Inc. 11.21M
Xencor, Inc. 61.52M